Ebola is a severe, often fatal illness that spreads through direct contact with body fluids.

Ebola is a severe, often fatal illness that spreads through direct contact with body fluids.
Image: Intellect (generated)

In short: Ebola is not a respiratory virus like the flu or COVID-19, meaning it does not spread through the air. Instead, it transmits through direct contact with the blood, secretions, or organs of infected humans or animals. While often fatal, early intensive supportive care significantly improves a patient's chances of survival.

Ebola disease is caused by viruses in the Orthoebolavirus genus, which were first identified in 1976 during simultaneous outbreaks in what is now South Sudan and the Democratic Republic of the Congo. The virus is named after the Ebola River, near the site of the latter outbreak. While there are six identified species of these viruses, only three—Ebola virus, Sudan virus, and Bundibugyo virus—are known to cause large human outbreaks. Fruit bats are considered the natural hosts of the virus, which enters the human population through contact with infected animals like chimpanzees, gorillas, or forest antelope.

Once in humans, the virus spreads through direct contact with the blood, body fluids, or contaminated objects of an infected person. Crucially, individuals are not contagious until they begin showing symptoms, which typically appear 2 to 21 days after exposure. Symptoms often begin suddenly with fever, fatigue, and muscle pain, sometimes progressing to vomiting, diarrhea, and impaired organ function. While bleeding is a common fear, it is less frequent than other symptoms and usually occurs later in the disease's progression.

Diagnosis is challenging because early symptoms mimic other diseases like malaria or typhoid fever, requiring laboratory confirmation via methods such as RT-PCR. For Ebola virus disease specifically, there are now approved vaccines, such as Ervebo, and monoclonal antibody treatments like mAb114 and REGN-EB3. For other Ebola diseases, such as Sudan virus disease, no approved therapeutics exist, though candidate products are in development. Regardless of the specific virus, optimized supportive care—including rehydration and symptom management—remains the cornerstone of increasing survival rates, which have historically varied from 25% to 90% across different outbreaks.

Opens the Intellect+ feed with this card first. Swipe up for the next one.

Sources

To cite this card, link to https://intellectplus.co.uk/app/science-ebola-virus.

How we source, check and correct cards: Editorial standards.

General information, not professional advice. Spotted an error? Flag the card or see corrections and complaints.

Intellect Plus is a visual educational discovery platform for exploring fascinating facts and ideas. Brain Food, Not Brain Rot. What is Intellect Plus?

Related

Finding something worth knowing…